WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1998049350) $i(IN VIVO) USE OF RECOMBINAGENIC OLIGONUCLEOBASES TO CORRECT GENETIC LESIONS IN HEPATOCYTES
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/1998/049350 International Application No.: PCT/US1998/008834
Publication Date: 05.11.1998 International Filing Date: 30.04.1998
Chapter 2 Demand Filed: 24.11.1998
IPC:
A61K 9/107 (2006.01) ,A61K 9/127 (2006.01) ,C12N 15/10 (2006.01)
Applicants: STEER, Clifford, J.[US/US]; US (UsOnly)
KREN, Betsy, T.[US/US]; US (UsOnly)
BANDYOPADHYAY, Paramita, T.[IN/US]; US (UsOnly)
REGENTS OF THE UNIVERSITY OF MINNESOTA[US/US]; 1100 Washington Avenue South Minneapolis, MN 55415-1226, US (AL, AM, AT, AU, AZ, BA, BB, BE, BF, BG, BJ, BR, BY, CA, CF, CG, CH, CI, CM, CN, CU, CY, CZ, DE, DK, EE, ES, FI, FR, GA, GB, GE, GH, GM, GN, GR, HU, IE, IL, IS, IT, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MC, MD, MG, MK, ML, MN, MR, MW, MX, NE, NL, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, SN, SZ, TD, TG, TJ, TM, TR, TT, UA, UG, UZ, VN, YU, ZW)
Inventors: STEER, Clifford, J.; US
KREN, Betsy, T.; US
BANDYOPADHYAY, Paramita, T.; US
Agent: HANSBURG, Daniel; Kimeragen, Inc. 300 Pheasant Run Newtown, PA 18940 , US
Priority Data:
60/045,28830.04.1997US
60/054,83705.08.1997US
60/064,99610.11.1997US
Title (EN) $i(IN VIVO) USE OF RECOMBINAGENIC OLIGONUCLEOBASES TO CORRECT GENETIC LESIONS IN HEPATOCYTES
(FR) UTILISATION $i(IN VIVO) D'OLIGONUCLEOBASES RECOMBINAGENES POUR CORRIGER LES LESIONS GENETIQUES DES HEPATOCYTES
Abstract:
(EN) The present invention concerns compositions and methods for the introduction of specific genetic changes in endogenous genes of the cells of an animal. The genetic changes are effected by oligonucleotides or oligonucleotide derivatives and analogs, which are generally less than about 100 nucleotides in length. The invention provides for macromolecular carriers, optionally incorporating ligands for clathrin coated pit receptors. In one embodiment the ligand is a lactose or galactose and the genetic changes are made in hepatocytes. By means of the invention up to 40 % of the copiies of a target gene have been changed $i(in vitro). Repair of mutant genes having a Crigler-Najjar like phenotype and Hemophilia B phenotype were observed.
(FR) L'invention porte sur des compositions et procédés d'introduction de modifications génétiques spécifiques dans des gènes endogènes des cellules d'un animal. Lesdites modifications sont opérées par des oligonucléotides ou leurs dérivés ou analogues normalement d'une longueur inférieure à environ 100 nucléotides. L'invention porte également sur des porteurs macromoléculaires comportant facultativement des ligands de 'pit receptors' à revêtement de clathrine. Dans l'une des exécutions, le ligand est du lactose ou du galactose et les modifications génétiques sont opérées par des hépatocytes. Cette invention a permis de modifier jusqu'à 40 % des copies d'un gène cible $i(in vitro). On a pu observer des réparations de gènes mutants présentant un phénotype du genre Crigler-Najjar et un phénotype du genre Hemophilia B.
Designated States: AL, AM, AU, BA, BB, BG, BR, CA, CN, CU, CZ, EE, GE, HU, IL, IS, JP, KP, KR, LC, LK, LR, LT, LV, MG, MK, MN, MX, NO, NZ, PL, RO, SG, SI, SK, SL, TR, TT, UA, US, UZ, VN, YU
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)